Evidence mapPaperPMID 36834531Full record

ReviewInternational journal of molecular sciences2023

PPARs and the Kynurenine Pathway in Melanoma-Potential Biological Interactions.

Katarzyna Walczak, Agnieszka Gerkowicz, Dorota Krasowska

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Katarzyna WalczakLaboratory for Immunology of Skin Diseases, Chair and Department of Dermatology, Venerology and Paediatric Dermatology, Medical University of Lublin, Radziwillowska 11, 20-080 Lublin, Poland.ORCID 0000-0001-5696-8289
Agnieszka GerkowiczChair and Department of Dermatology, Venerology and Paediatric Dermatology, Medical University of Lublin, Staszica 11Ł, 20-081 Lublin, Poland
Dorota KrasowskaChair and Department of Dermatology, Venerology and Paediatric Dermatology, Medical University of Lublin, Staszica 11Ł, 20-081 Lublin, PolandORCID 0000-0002-3176-9870
Medical University of Lublin · PL

Funding

Medical University of Lublin DzSt 167/2022
6 · The paper itself

Abstract

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors involved in various physiological and pathological processes within the skin. PPARs regulate several processes in one of the most aggressive skin cancers, melanoma, including proliferation, cell cycle, metabolic homeostasis, cell death, and metastasis. In this review, we focused not only on the biological activity of PPAR isoforms in melanoma initiation, progression, and metastasis but also on potential biological interactions between the PPAR signaling and the kynurenine pathways. The kynurenine pathway is a major pathway of tryptophan metabolism leading to nicotinamide adenine dinucleotide (NAD+) production. Importantly, various tryptophan metabolites exert biological activity toward cancer cells, including melanoma. Previous studies confirmed the functional relationship between PPAR and the kynurenine pathway in skeletal muscles. Despite the fact this interaction has not been reported in melanoma to date, some bioinformatics data and biological activity of PPAR ligands and tryptophan metabolites may suggest a potential involvement of these metabolic and signaling pathways in melanoma initiation, progression, and metastasis. Importantly, the possible relationship between the PPAR signaling pathway and the kynurenine pathway may relate not only to the direct biological effect on melanoma cells but also to the tumor microenvironment and the immune system.

Indexed as

MelanomaSkin NeoplasmsHumansKynureninePeroxisome Proliferator-Activated ReceptorsTryptophanTumor MicroenvironmentKynureninePeroxisome Proliferator-Activated ReceptorsTryptophancell cyclecell deathkynurenic acidkynureninekynurenine pathwaymelanomametabolismperoxisome proliferator-activated receptorproliferation

Identifiers

PMID36834531
PMCPMC9960262
OpenAlexW4319318429

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.